Novel mechanism by which hemoglobin induces constriction of cerebral arteries

European Journal of Pharmacology

Volumn 361, Issue 2-3, 1998, Pages 311-319

  Vollrath, Bozena ^a   Cook, David ^a   Megyesi, Joseph ^a   Findlay, J Max ^a   Ohkuma, Hiroki ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cerebral vasospasm; Genistein; Hemoglobin; Tyrosine phosphorylation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DAIDZEIN; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OXYHEMOGLOBIN; PROTEIN TYROSINE KINASE; SUPEROXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ARTERY; BRAIN VASOSPASM; CELL CULTURE; CONTROLLED STUDY; DOG; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SUBARACHNOID HEMORRHAGE; WESTERN BLOTTING;

ANIMALS; CEREBRAL ARTERIES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMOGLOBINS; MALE; OXYHEMOGLOBINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; TIME FACTORS; TYROSINE; VASOCONSTRICTION;

EID: 0032553626     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00745-6     Document Type: Article

References (43)

1. Adam L.P., Hathaway D.R. Identification of mitogen-activated protein kinase phosphorylation sequences in mammalian h-caldesmon. FEBS Lett. 322:1993;56-60.
2. Adam L.P., Gapinski C.J., Hathaway D.R. Phosphorylation sequences in h-caldesmon from phorbol ester-stimulated canine aortas. FEBS Lett. 303:1992;223-226.
3. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5595.
4. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
5. Auch-Schwelk W., Katusic Z.S., Vanhoutte P.M. Contractions to oxygen-derived free radicals are augmented in the aorta of the spontaneously hypertensive rat. Hypertension. 13:1989;859-864.
6. 2 in vascular smooth muscle cells. Circ. Res. 77:1995;29-36.
7. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein, utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
8. Childs T.J., Watson M.H., Sanghera J.S., Campbell D.L., Pelech S.L., Mak A.S. Phosphorylation of smooth muscle caldesmon by mitogen-activated protein (MAP) kinase and expression of MAP kinase in differentiated smooth muscle cells. J. Biol. Chem. 267:1992;22853-22859.
9. Cook D.A., Vollrath B. Free radicals and intracellular events associated with cerebrovascular spasm. Cardiovasc. Res. 30:1995;493-500.
10. Cook, D.A., Luong, T., Doi, M., Vollrath, B., 1993. Prolonged activation of protein kinase C in oxyhemoglobin-induced vasoconstriction in canine basilar artery. In: Findlay, J.M. (Ed.), Cerebral Vasospasm. Elsevier, Amsterdam, pp. 125-128.
11. Cooper J.A., Howell B. The when and how of Src regulation. Cell. 73:1993;1051-1054.
12. Crews C.M., Alessandrini A., Erikson R.L. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science. 258:1992;478-480.
13. Devary Y., Gottlieb R.A., Smeal T., Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell. 71:1992;1081-1091.
14. Dikic I., Tokiwa G., Lev S., Courtneige S.A., Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature (London). 383:1996;547-550.
15. Di Salvo J., Steusloff A., Semenchuk L., Satoh S., Kolquist K., Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem. Biophys. Res. Commun. 190:1993;968-974.
16. Khalil R.A., Morgan K.G. PKC-mediated redistribution of mitogen-activated protein kinase during smooth muscle cell activation. Am. J. Physiol. 265:1993;C406-C411.
17. Kooy N.W., Royall J.A., Ischiropoulos H., Beckman J.S. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic. Biol. Med. 16:1994;149-156.
18. Kyriakis J.M., Avruch J.S. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:1996;24313-24316.
19. Lander H.M. An essential role for free radicals and derived species in signal transduction. FASEB J. 11:1997;118-124.
20. ras as a common signalling target of reactive free radicals and cellular redox stress. J. Biol. Chem. 270:1995;21195-21198.
21. Lander H.M., Milbank A.J., Tauras J.M., Hajjar D.P., Hempstead B.L., Schwartz G.D., Kraemer R.T., Mirza U.A., Chait B.T., Campbell-Burk S., Quilliam L.A. Redox regulation of cell signalling. Nature (London). 381:1996;380-381.
22. 2+-induced regulation of ion channel and MAP kinase functions. Nature (London). 376:1995;737.
23. Macdonald R.L., Weir B.K.A. Cerebral vasospasm and free radicals. Free Radic. Biol. Med. 16:1994;633-643.
24. Macdonald R.L., Weir B.K.A., Runzer T.D., Grace M.G.A., Findlay J.M., Saito K., Cook D.A., Mielke B.W., Kanamaru K. Etiology of cerebral vasospasm in primates. J. Neurosurg. 75:1991;415-424.
25. Martin W., Villani G.M., Jothianandan D., Furchgott R.F. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by certain ferrous hemoproteins. J. Pharmacol. Exp. Ther. 23:1985;679-685.
26. Mayberg M.R., Okada T., Bark D.H. The role of hemoglobin in arterial narrowing after SAH. J. Neurosurg. 72:1990;634-640.
27. Mayberg M.R., Okada T., Bark D.H. The significance of morphological changes in cerebral arteries after subarachnoid hemorrhage. J. Neurosurg. 72:1990;626-633.
28. Onoue H., Kaito N., Akiyama M., Tomii M., Tokudome S., Abe T. Altered reactivity of human cerebral arteries after subarachnoid hemorrhage. J. Neurosurg. 83:1995;510-515.
29. Pluta M.R., Afshar J.K.B., Boock R.J., Oldfield E.H. Temporal changes in perivascular concentrations of oxyhemoglobin after subarachnoid hemorrhage. J. Neurosurg. 88:1998;557-561.
30. Robinson M.J., Cobb M.H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:1997;180-186.
31. Sako M., Nishikaro J., Ohta S. Role of protein kinase C in the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 13:1993;247-254.
32. Sasaki H., Nagura K., Ishino M., Tobioka H., Kotani K., Sasaki T. Cloning and characterization of cell adhesion kinase β, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J. Biol. Chem. 270:1995;21206-21219.
33. Seger R., Krebs E.G. The MAPK signalling cascade. FASEB J. 9:1995;726-735.
34. Seger R., Ahn N.G., Boulton T.G., Yancopoulos G.D., Panayotatos N., Radziejewska E., Ericksson L., Bratlier R.L., Cobb M.H., Krebs E.G. Microtubule-associated protein 2-kinases, ERK1 and ERK2 undergo autophosphorylation on both tyrosine and threonine residues: implication for their mechanism of activation. Proc. Natl. Acad. Sci. USA. 88:1991;6142-6146.
35. Shishido T., Suzuki R., Qian L., Hirokawa K. The role of superoxide anions in the pathogenesis of cerebral vasospasm. Stroke. 25:1994;864-868.
36. Steele J.A., Stockbridge N., Maljkovic G., Weir B. Free radicals mediate actions of oxyhemoglobin on cerebrovascular smooth muscle cells. Circ. Res. 68:1991;416-423.
37. Takanashi Y., Weir B.K.A., Vollrath B., Kasuya H., Macdonald R.L., Cook D. The time course of changes in the concentration of intracellular free calcium in cultured cerebrovascular smooth muscle cells after prolonged exposure to oxyhemoglobin. Neurosurgery. 30:1992;346-350.
38. Takenaka, K., Goto, Y., Kassell, N.F., Lee, K.S., 1993. Modification of vascular smooth muscle proteins in rabbit basilar artery after subarachnoid hemorrhage. In: Findlay, J.M. (Ed.), Cerebral Vasospasm. Elsevier, Amsterdam, pp. 93-96.
39. Takuwa Y., Matsui T., Abe Y. Alterations in protein kinase C activity and membrane lipid metabolism in cerebral vasospasm after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 13:1993;409-415.
40. Varsos V.G., Liszczak T.M., Zervas N.T. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a 'two-hemorrhage' canine model. J. Neurosurg. 58:1983;11-17.
41. Vollrath B., Weir B.K.A., Macdonald R.L., Cook D.A. Intracellular mechanisms involved in the responses of cerebrovascular smooth muscle cells to hemoglobin. J. Neurosurg. 58:1994;261-268.
42. Vollrath B., Chan P., Findlay J.M., Cook D.A. Lazaroids and deferoxamine attenuate the intracellular effects of oxyhaemoglobin in vascular smooth muscle. Cardiovasc. Res. 30:1995;619-626.
43. Wiseman H., Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313:1996;17-29.